More cases of drug-resistant tuberculosis complicate care but spur global research and innovation.
Wilson
Jennifer Fisher
JF
Annals of Internal Medicine. jenwilson@acponline.org
D000995:Antitubercular Agents / Q000191:economics / Q000627:therapeutic use*; D017281:Cost of Illness; D004196:Disease Outbreaks / Q000191:economics*; D055808:Drug Discovery; D004345:Drug Industry / Q000191:economics; D006801:Humans; D018088:Tuberculosis, Multidrug-Resistant / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology*
D000995:Antitubercular Agents